R efractive errors are common optical aberrations determined by mismatches in the focusing power of the cornea, lens and axial length of the eye. Their distribution worldwide is rapidly shifting toward myopia, or nearsightedness. The myopia boom is particularly prominent in urban East Asia, where up to 95% of 20-year-olds in cities such as Seoul and Singapore have this Refractive errors, including myopia, are the most frequent eye disorders worldwide and an increasingly common cause of blindness. This genome-wide association meta-analysis in 160,420 participants and replication in 95,505 participants increased the number of established independent signals from 37 to 161 and showed high genetic correlation between Europeans and Asians (> 0.
refractive error [1] [2] [3] [4] . The prevalence of myopia is also rising throughout Western Europe and the United States, affecting ~50% of young adults in these regions 5, 6 . Although refractive errors can be optically corrected, even at moderate values they carry substantial risk of ocular complications with high economic burden [7] [8] [9] . One in three individuals with high myopia (-6 diopters or worse) develop irreversible visual impairment or blindness, mostly as a result of myopic macular degeneration, retinal detachment or glaucoma 10, 11 . At the other extreme, high hyperopia predisposes individuals to strabismus, amblyopia and angle-closure glaucoma 10, 12 .
Refractive errors result from a complex interplay of lifestyle and genetic factors. The most established lifestyle factors for myopia are high education, lack of outdoor exposure and excessive near work 3 . Recent research has identified many genetic variants for refractive errors, myopia and axial length [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] . Two large studies-the International Consortium for Refractive Error and Myopia (CREAM) 26 and the personal genomics company 23andMe, Inc. 17, 27 -have provided the most comprehensive results 28 .
Given that only 3.6% of the variance of the refractive-error trait was explained by the identified genetic variants 26 , we presumed a high missing heritability. We therefore combined data from CREAM and 23andMe, and expanded the study sample to 160,420 individuals from a mixed-ancestry population with quantitative information on refraction for a genome-wide association study (GWAS) meta-analysis. Index variants were tested for replication in an independent cohort consisting of 95,505 individuals from the UK Biobank. We conducted systematic comparisons to assess differences in genetic inheritance and the distribution of risk variants between Europeans and Asians. Polygenic risk analyses were performed to evaluate the contributions of the identified variants to the risk of myopia and hyperopia. Finally, we integrated expression data and bioinformatics on the identified genes to gain insight into the possible mechanisms underlying the genetic associations.
Results
Susceptibility loci for refractive error. We performed a GWAS meta-analysis on adult untransformed spherical equivalent (SphE), using summary statistics from 37 studies from CREAM, and on age of diagnosis of myopia (AODM) from two cohorts from 23andMe 26, 27 (Supplementary Fig. 1 and Supplementary Table 1a ). The analyses were based on ~11 million genetic variants (SNPs, insertions and deletions) genotyped or imputed to the 1000 Genomes Project Phase I reference panel (version 3, March 2012 release 29 ) that passed extensive quality control ( Supplementary  Figs. 2-4 and Supplementary Table 1b ).
Meta-analyses were conducted in three stages: stage 1, CREAM (European dataset, CREAM-EUR, number of participants (n) = 44,192; Asian dataset, CREAM-ASN, n = 11,935); stage 2, 23andMe (n = 104,293; Methods); stage 3, joint meta-analysis of stages 1 and 2. Because CREAM and 23andMe applied different phenotype measures, we used signed Z scores as the mean per-allele effect size and assigned equal weights to CREAM and 23andMe. We identified 7,967 genome-wide-significant genetic variants clustering in 140 loci ( Fig. 1a,b , Supplementary Figs. 5 and 6, Supplementary Tables 2-5 and Supplementary Data 1 and 2), replicating all 37 previously discovered loci and finding 104 novel loci. We applied genomic control at each stage and checked for population stratification by using linkage disequilibrium (LD)-score regression 30 (stage 1 and 2 inflation factors (GC) < 1.1 and LD-score regression intercepts (LDSC intercept ) 0.892-1.023; Supplementary  Table 6 and Supplementary Figs. 6 and 7) . At stage 3, we observed genomic inflation (λ GC = 1.129; Supplementary Fig. 6 ), probably because of true polygenicity rather than population stratification or cryptic relatedness 31 . LDSC intercept remained undetermined, owing to mixed ancestry.
To detect the presence of multiple independent signals at the discovered loci, a stepwise conditional analysis was performed with GCTA-COJO 32 on summary statistics from all European cohorts (n = 148,485), with the Rotterdam Study I-III (RSI-III) used as a reference panel for LD structure (n RSI-III = 10,775). This analysis yielded 27 additional independent variants, thus resulting in a total of 167 loci (Supplementary Table 2 ).
We advanced these loci for replication in a GWAS of refractive error carried out by the UK Biobank Eye & Vision (UKEV) Consortium (n = 95,505) 33 (Methods) . Six out of the 167 variants were not considered for replication analysis. One of these five variants (rs3138141, RDH5) was identified previously and therefore still considered a refractive-error risk variant 26, 27 . The remaining 161 genetic variants were tested for replication. Among the candidate variants, 86% (138/161) replicated: 104 (65%) replicated surpassing genome-wide significance, and 34 replicated surpassing Bonferroni correction (P < 3.0 × 10 −4 ; 21.1%); another 12 showed nominal evidence for replication (0.05 < P < 3.0 × 10 −4 ; 7.5%); and only 11 (7%) did not replicate at all (Table 1 and Supplementary Table 2 ).
Because CREAM and 23andMe used different phenotypic outcomes, we evaluated the consistency of genotypic effects by comparing marker-wise additive genetic effect sizes (in diopters per risk-allele variant) for SphE from CREAM-EUR against those (in log(hazard ratio(HR)) per risk-allele variant) for AODM from 23andMe. All variants that were strongly associated with either outcome (P < 0.001) were concordant in direction of effect and had highly correlated effect sizes ( Fig. 2a,b and Supplementary  Fig. 8 ). For these variants, a 10% decrease in log(HR) for AODM, indicating an earlier age at myopia onset, was associated with a decrease of 0.15 diopters in SphE. A quantitative analysis of all common SNPs (minor allele frequency (MAF) > 0.01; HapMap3) through LD-score regression yielded a genetic correlation of 0.93 (95% confidence interval (CI) 0.86-0.99; P = 2.1 × 10 −159 ), thus confirming that the effect sizes for both phenotypic outcomes were closely related.
Gene annotation of susceptibility loci.
We annotated all genetic variants with wANNOVAR by using the University of California Santa Cruz (UCSC) Known Gene database (see URLs) 34 . The 139 identified genetic loci were annotated to 208 genes and known transcribed RNA genes (Table 1, Supplementary Table 2 and Methods). The physical positions of the lead genetic variants relative to proteincoding genes are shown in Fig. 1c . 86% of the identified variants were either intragenic or less than 50 kb from the 5′ or 3′ end of the transcription start site. We found seven exonic variants ( Supplementary  Table 7 ), of which two had MAF ≤ 0.05: rs5442 (GNB3) and rs17400325 (PDE11A). The index SNP in the GNB3 locus with MAF 0.05 in Europeans is a highly conserved missense variant (p.Gly272Ser) predicted to be damaging by PolyPhen-2 (ref. 35 ) and SIFT 36 . PDE11A is presumed to play a role in tumorigenesis, brain function and inflammation 37 . The index SNP in the PDE11A locus with MAF 0.03 in Europeans is also a highly conserved missense variant (p.Tyr727Cys); this variant was predicted to be damaging by PolyPhen-2, SIFT 38 and align GVGD 39, 40 .The other exonic variants, rs1064583 (COL10A1), rs807037 (KAZALD1), rs1550094 (PRSS56), rs35337422 (RD3L) and rs6420484 (TSPAN10), were not predicted to be damaging.
The most significant variant (stage 3; rs12193446, P = 4.21 × 10 −84 ) resides on chromosome 6 within a noncoding-RNA sequence, BC035400, in an intron of the LAMA2 gene. This locus had been identified previously, but our current fine mapping redefined the most associated variant. The function and potential downstream target sites of BC035400 are currently unknown. The previously most strongly associated variant, rs524952 on chromosome 15 near GJD2, was the second most significant variant (P = 2.28 × 10 −65 ).
Post-GWAS analyses. We performed two gene-based tests, fast-BAT 41 and EUGENE 42 , and applied a functional enrichment approach with fgwas 43 (Methods). With fastBAT, we identified 13 genes at P < 2.0 × 10 −6 , one of which (CHD7) had been identified previously 26, 27 . Using EUGENE, we found seven genes at P < 2.0 × 10 −6 after incorporation of blood expression quantitative trail loci (eQTLs). With fgwas, we identified six loci, which were annotated to nine genes, at a posterior probability > 0.9. Two genes (HMGN4 and TLX1) showed significant associations in two or more approaches. Together, these post-GWAS approaches resulted in a total of 22 additional candidate loci for refractive error, annotated to 25 genes ( Supplementary Table 8 ). These results increase the overall number of significant genetic associations to 161 candidate loci.
Polygenic risk scores. We calculated polygenic risk scores (PGRS) 44 per individual at various P thresholds (Methods) for RSI-III (n = 10,792) after recalculating P and Z scores of variants from stage 3 excluding RSI-III. The highest fraction of phenotypic variance (7.8%) was explained with 7,307 variants at a P-value threshold of 0.005 ( Supplementary Table 9 ). A PGRS based on these variants distinguished between individuals with hyperopia and myopia at the lower and higher deciles ( Fig. 3) ; those in the highest decile had a 40-fold-greater risk of myopia. When the PGRS was stratified for the median age (< 63 or > 63 years), we found a significant difference in the variance explained (< 63 years, 8.9%; > 63 years, 7.4%; P = 0.0038). The variance explained by PGRS was not significantly different between males and females (stage 3) . a, Meta-analysis of genome-wide single-variant analyses for > 10 million variants in 160,420 CREAM and 23andMe participants (stage 3). Shown is a Manhattan plot depicting P for association, highlighting newly identified (P < 5 × 10 −8 ; green) and known (dark gray) refractive-error loci previously found by using HapMap II imputations from Kiefer et al. 27 and Verhoeven et al. 26 ( Table 1 ). The horizontal lines indicate suggestive significance (P = 1 × 10 −5 ) or genome-wide significance (P = 5 × 10 −8 ). 1000G, 1000 Genomes Project. b, MAFs of the 140 discovered index variants based on 1000G (blue, Europeans; red, Asians) to the MAFs of the previously found genetic variants based on HapMap II (green, Europeans; purple, Asians). An increase was observed in genetic variants found across all MAF bins, including the lower MAF bins. c, Annotation of the 167 loci to genes in wANNOVAR. Shown are the distances between index variants from the nearest gene and its gene on the 5′ and/or 3′ site. Most index variants (84%) were at a distance of less than 50 kb up-or downstream from the annotated gene. We identified 140 loci for refractive error with genome-wide significance (P < 5 × 10 −8 ) on the basis of the meta-analyses of the genome-wide single-variant linear regressions performed in 160,420 participants of mixed ancestries (CREAM-ASN, CREAM-EUR and 23andMe).
Shown are the replication of the previously found loci from HapMap II and a subset of the new loci with the smallest P values. For each locus, represented by an index variant (the variant with the smallest P value in that locus), effect allele, other allele, effect-allele frequencies per ancestry (EAF ASN and EAF EUR), effect size (Z score), direction of the effect (direction), the P value, heterogeneity I square (Het Isq), heterogeneity P value (Het P value), sample size (n) and P value of the replication in UK Biobank are shown (full table in Supplementary Table   2 ). ASN, Asian; EUR, European; GWS, genome wide significant; NA, not applicable.
Table 1 |
Results of the meta-analysis of CREAM and 23andMe for the previously identified loci and a subset of the newly identified loci, and replication in UK Biobank (Continued) (8.3 vs. 7.5%, respectively; P = 0.13). The predictive value (area under the receiver operating characteristic curve) of the PGRS for myopia vs. hyperopia, adjusted for age and sex, was 0.77 (95% CI = 0.75-0.79), a value 10% higher than previous estimations 45 .
Transancestral comparison of genotypic effects. To explore potential ancestry differences in the identified refractive-error loci, we calculated the heritability explained by common genetic variants (SNP-h 2 ) for Europeans and Asians, by using LD-score regression 46 . The SNP-h 2 was 0.214 (95% CI 0.185-0.243) and 0.172 (95% CI 0.154-0.190) in the European samples (CREAM-EUR and 23andMe, respectively), but was only 0.053 (95% CI -0.025-0.131) in the Asian sample (CREAM-EAS). Next, we estimated the genetic correlation between Europeans and Asians by comparing variant effect sizes for common variants in Popcorn 47 (Methods). Two genetic correlation metrics were calculated: (i) a genetic-effect correlation (ρge) that quantifies the correlation in SNP effect sizes between Europeans and Asians without taking into account ancestry-related differences in allele frequency and (ii) a genetic-impact correlation (ρgi) that estimated the correlation in variance-normalized SNP effect sizes between the two ancestry groups ( Table 2 ). Estimates of ρge were high between Europeans and Asians, but were significantly different from 1 (0.79 and 0.80, respectively, at P < 1.9 × 10 −6 ; Table 2 ), thus indicating a clear genetic overlap but a difference in per-allele effect size. Estimates of ρgi were similarly high (> 0.8) but were not significantly different from 1 for the correlation between CREAM-EUR and CREAM-ASN (P = 0.065), thus indicating that the genetic impact of these alleles may still be similar.
In silico pathway analysis. We used an array of bioinformatics tools to investigate potential functions and pathways of the associated genes. We first used DEPICT 48 to perform a gene set enrichment analysis, a tissue-type enrichment analysis and a gene prioritization analysis, on all variants with P < 1.00 × 10 −5 from stage 3. The gene set enrichment analysis resulted in 66 reconstituted gene sets, of which 55 (83%) were eye related. To decrease redundancy among pathways, we clustered the significant pathways into 13 meta-gene sets (false discovery rate (FDR) < 5% and P < 0.05) (Supplementary Note, Fig. 4 and Supplementary Table 10 ). The most significant gene set was 'abnormal photoreceptor inner segment morphology' (Mammalian Phenotype Ontology (MP) 0003730; P = 1.79 × 10 −7 ). The eye-related meta-gene sets consisted of 'thin retinal outer nuclear layer' (MP 0008515; 27 (55%) gene sets), 'detection of light stimulus' (Gene Ontology (GO) 0009583; 13 (24%) gene sets), 'nonmotile primary cilium' (GO 0031513; 4 (6%) gene sets) and 'abnormal anterior-eye-segment morphology' (MP 0005193; 4 (6%) gene sets). The first three meta-gene sets had a Pearson's correlation > 0.6. Interestingly, RGR, RP1L1, RORB and GNB3 were present in all of these meta-gene sets. The retina was the most significant tissue of expression according to the tissue-type enrichment analysis (P = 1.11 × 10 −4 , FDR < 0.01). From the gene prioritization according to DEPICT, seven genes were highlighted as the most likely causal genes at P < 7.62 × 10 −6 and FDR < 0.05: ANO2, RP1L1, GNB3, EDN2, RORB and CABP4.
Next, we performed a canonical pathway analysis on all genes annotated to the variants of stage 3, by using Ingenuity Pathway Analysis (IPA; see URLs). All genes were run against the IPA database incorporating functional biological evidence on genomic and proteomic expression according to regulation or binding studies. IPA identified 'glutamate receptor signaling' with the central player NF-κ B as the most significant pathway after correction for multiple testing (ratio of the number of molecules, 8.8%; Fisher's exact P = 1.56 × 10 −4 ; Supplementary Fig. 9 ).
From disease-associated loci to biological mechanisms. We adapted the scoring scheme designed by Fritsche et al. 49 to highlight genes with biologically plausible roles in eye growth. We used ten equally rated categories (Methods, Fig. 5 , Supplementary Table 11 and Supplementary Note). We found that 109 index variants replicated in two or more individual cohorts; there was evidence for seven genetic variants with eQTL effects in multiple tissue types; nine exonic variants, seven of which predicted protein alterations (Supplementary Table 7 ); 31 RNA genes, five of which were located in the 3′ or 5′ untranslated region (UTR) ( Supplementary  Table 12 and Supplementary Fig. 10 ); 84 genes resulting in an ocular phenotype in humans ( Supplementary Table 13 ) and 36 in mice ( Supplementary Table 14 ); 172/212 (81%) genes expressed in human ocular tissue (Supplementary Note and Supplementary  Table 15 ); 41 genes identified by DEPICT at P < 5.4 × 10 −4 and FDR < 0.05; and 45 genes that contributed to the most significant canonical IPA pathways. Notably, 48 of the associated genes encode known drug targets (Supplementary Table 16 ).
The gene with the highest biological-plausibility score (score = 8) was GNB3, a highly conserved gene encoding a G-nucleotidebinding protein expressed in rod and cone photoreceptors and ON bipolar cells 50 . GNB3 participates in signal transduction through G-protein-coupled receptors and enhances the temporal accuracy GNB3 GNB3 
Fig. 5 | Genes ranked according to biological and statistical evidence.
Genes ranked (orange) according to ten equal categories that can be grouped into the following: internal replication of genetic variant in two or more cohorts (purple; CREAM-EUR, CREAM-ASN and/or 23andMe); annotation (light blue; genetic variant bearing an exonic protein-altering variant or non-protein-altering variant, genetic variant residing in a 5′ or 3′ UTR of a gene or transcribing an RNA structure); expression (yellow; eQTL, expression in adult human ocular tissue, expression in developing ocular tissue); biology (dark yellow; ocular phenotype in mice, ocular phenotype in humans); pathways (green; DEPICT gene set enrichment, DEPICT gene-prioritization analysis and IPA canonical pathway analysis). We assessed genes bearing drug targets (salmon red) but did not assign a scoring point to that category. Asterisk indicates that only one point could be assigned for 'annotation', even though it has four columns (i.e., a genetic variant is located in only one of these four categories).
of phototransduction and ON-center signaling in the retina 50 . As described above, the index SNP contains a missense variant associated with refractive errors. Nonsynonymous mutations within GNB3 are known to cause syndromic congenital stationary night blindness 51 in humans; progressive retinopathy and globe enlargement in chickens 50 ; and abnormal development of the photoreceptor-bipolar synapse in knockout mice 52, 53 .
Other highly ranked (score = 7) genes included CYP26A1, GRIA4, RDH5, RORB and RGR, all previously associated with refractive error, and one newly identified gene, EFEMP1. EFEMP1 encodes a member of the fibulin family of extracellular-matrix glycoproteins and is found panocularly, including in the inner nuclear layer and Bruch's membrane. Mutations in this gene lead to specific macular dystrophies 54 , whereas variants have also been shown to cosegregate with primary open-angle glaucoma 55 and to be associated with optic disc cup area 56 .
Several other genes were noteworthy for their function. CABP4, which encodes a calcium-binding protein expressed in cone and rod photoreceptor cells, mediates Ca 2+ influx and glutamate release in the photoreceptor bipolar synapse 57 . Mutations in this gene have been described in congenital cone-rod synaptic disorder 58 , a retinal dystrophy associated with nystagmus, photophobia and high hyperopia. KCNMA1 encodes pore-forming alpha subunits of Ca 2+ -activated K + channels. These channels regulate synaptic transmission exclusively in the rod pathway 59 . ANO2 encodes a Ca 2+ -activated Clchannel recently reported to regulate retinal pigment epithelium (RPE) cell volume in a lightdependent manner 60 . EDN2 encodes a potent vasoconstrictor that binds to two G-protein-coupled receptors encoded by EDNRA, which resides on bipolar dendrites, and the protein product of EDNRB, which is present on Mueller and horizontal cells. Both receptors are also present on choroidal vessels 61 , thus implying that the choroid as well as retinal cells are target sites of this gene. RP1L1 is expressed in cone and rod photoreceptors, where it is involved in the maintenance of microtubules in the connecting cilium 62 . Mutations in this gene cause dominant macular dystrophy and retinitis pigmentosa 63 . We replicated two genes involved in myopia in family studies: (i) FBN1, which bears mutations causing Marfan (MIM 154700) and Weil Marchesani (MIM 608328) syndromes, and (ii) PTPRR, one of the candidates in the MYP3 locus, which was identified on the basis of linkage in families with high myopia 64 .
The location of rs7449443 (P = 3.58 × 10 −8 ) is notable because it resides between DRD1 and LINC01951. DRD1 encodes dopamine receptor 1 and is known to modulate dopamine receptor 2-mediated events 65, 66 . The dopamine pathway has been implicated in myopia pathogenesis in many studies 65, 67 . SNPs in and near other genes involved in the dopamine pathway (dopamine receptor binding, synthesis, degradation and transport) 68-70 did not show genomewide-significant associations (Supplementary Note, Supplementary  Table 17 and Supplementary Fig. 11 ).
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Retinal expression (cell type not specified) and Supplementary Table 12 ). Our ranking of genes according to functional information existing in the public domain does not necessarily represent the true order of importance for refractive-error pathogenesis. The observation that genes with strong statistical association were distributed over all scores supports this concept. Nevertheless, this list may aid in selection of genes for subsequent functional studies. Finally, integration of all our findings together with literature allowed us to annotate a large number of genes to ocular cell types (Fig. 6 ). All cell types of the retina contained refractive-error genes, as well as RPE, vascular endothelium and extracellular matrix. Genetic pleiotropy. We performed a GWAS catalog lookup, using FUMA to investigate the overlap of genes with other common traits 71 ( Supplementary Fig. 12 ). Refractive error and hyperopia were replicated significantly after correction for multiple testing (adjusted P value = 1.44 × 10 −52 and 9.34 × 10 −9 , respectively). We found significant overlap with 74 other traits, of which height (adjusted P value = 1.11 × 10 −10 ), obesity (adjusted P = 1.38 × 10 −10 ) and body mass index (adjusted P = 4.05 × 10 −7 ) were most important. Ocular diseases significantly associated were glaucoma (optic cup area and intraocular pressure, adjusted P = 2.69 × 10 −5 and 3.01 × 10 −5 , respectively) and age-related macular degeneration (adjusted P = 1.27 × 10 −3 ).
Discussion
Myopia may become the leading cause of blindness worldwide in the near future, which suggests a grim outlook for which current counteractions remain insufficient 11, 72 . To improve understanding of the genetic landscape and biology of refractive error, we conducted a large GWAS meta-analysis in 160,420 participants of mixed ancestry with replication in 95,505 participants. This study led to the identification of 139 independent susceptibility loci through singlevariant analysis and 22 additional loci through post-GWAS methods, representing a fourfold increase in refractive-error genes. Most annotated genes were found to be expressed in the human posterior segment of the eye. Using in silico analysis, we identified significant biological pathways, of which retinal cell physiology, light processing and, specifically, glutamate receptor signaling were the most prominent mechanisms. Our integrated bioinformatic approach highlighted known ocular functionality for many genes.
To ensure the robustness of our genetic associations, we included studies of various designs and populations; sought replication in an independent cohort of significant sample size; and stringently accounted for population stratification by performing genomic control at all stages of the meta-analysis 73 . We combined studies with outcomes based on actual refractive-error measurements, as well as on the self-reported age of myopia onset, and found the direction of effect of the associated variants, as well as their effect size, to be highly consistent. Combining two different outcome measures may appear unconventional, but age of onset and refractive error have been shown to be very tightly correlated 11, 28, 74, 75 . Moreover, the high genetic correlation (93%) of common SNPs between the two phenotypes underscores their similarity. The most compelling evidence was provided by replication of 86% of the discovered variants in the independent UKEV data, which also used conventional refractive-error measurements. This robustness indicates that both phenotypic outcomes can be used to capture a shared source of genetic variation. In addition, we found transancestral replication of significant loci and a high correlation of genetic effects of common variants in Europeans and Asians. Our findings support a largely shared genetic predisposition to refractive error and myopia in the two ancestries, although ancestry-specific allelic effects may exist. The low heritability estimate in Asians may be partly explained by the low representation of this ancestral group in our study sample; alternatively, it may imply that environmental factors explain a greater proportion of the phenotypic risk and recent rise in myopia prevalence in this ancestry group 76 .
Limitations of our study were the possibility of false-negative findings due to genomic control and underrepresentation of studies including individuals of Asian ancestry. The heterogeneity of the observed effect estimates was large for several associated variants, but this result was not unexpected, given the large number of collaborating studies with varying methodology.
Although neurotransmission was a previously suggested pathway 26, 27 , our current pathway analyses provide more in-depth insights into the retinal circuitry driving refractive error. DEPICT identified 'thin retinal outer nuclear layer' , 'detection of light stimulus' and 'nonmotile primary cilium' as the most important metagene sets. These are the main characteristics of photoreceptors, which are located in the outer retina and contain cilia. These photosensitive cells drive the phototransduction cascade in response to light, which in turn induces visual information processing. IPA indicated 'glutamate receptor signaling' as the most significant pathway. Glutamate is released by photoreceptors and determines conductance of retinal signaling to the ON and OFF bipolar cells 77 . Our functional gene lookups provide evidence that rod (CLU) as well as cone (GNB3) bipolar cells play a role. Together, these findings strongly suggest that light response and light processing in the retina are initiating factors leading to refractive error.
The genetic association with light-dependent pathways may also be linked to the well-established protective effect of outdoor exposure on myopia. We found evidence suggesting a genetic association with DRD1. The dopaminergic pathway has been studied extensively in animal models for its role in controlling eye growth in response to light 65, 67, [78] [79] [80] [81] [82] [83] [84] [85] [86] [87] . DRD1 has been found to be a mediator in this process, because bright light increases DRD1 activity in the bipolar ON pathway, and diminishes form-deprivation myopia in mice. Blockage of DRD1 reverses this inhibitory effect 88 . We did not find evidence of direct involvement of other genes in the dopamine pathway, but GNB3 may be an indirect modifier, because it is a molecule involved in dopamine downstream signaling and has been shown to influence the availability of the dopamine transporter DAT 89 . Although it is a promising target for therapy, further evidence of DRD1 in human myopiagenesis is warranted.
Novel pathways implicated by the newly identified genes are anterior-segment morphology (TCF7L2, VIPR2 and MAF) and angiogenesis (FLT1). In addition, the high number of variants residing near genes encoding small RNAs suggests that post-transcriptional regulation is an important mechanism, because these RNAs are known to play a distinct and central regulatory role in cells 90 . These findings should serve as leads for future studies performing detailed mapping of cellular networks as well as for functional studies on genes that have been implicated in ocular phenotypes, that have protein-altering variants and that are proven drug targets.
Our evaluation of shared genetics between refractive error and other disease-relevant phenotypes highlighted overlap with anthropometric traits such as height, obesity and body mass index. These findings may provide valuable additional clues regarding the phenotypic outcomes of perturbations of some of the networks identified.
Our genetic observations add credence to the current notion that refractive errors are caused by a retina-to-sclera signaling cascade that induces scleral remodeling in response to light stimuli. The concept of this cascade originates from various animal models showing that form deprivation, retinal defocus and contrast, ambient light and wavelength influence eye growth in young animals [91] [92] [93] . The cellspecific moieties in this putative signaling cascade in humans are largely unknown, although animal models have implicated GABA, dopamine, all-trans retinoic acid and TGF-β (refs 65, 87, 94, 95 ). Our study provides a large number of new molecular candidates for this cascade and clearly implicates a wide range of neuronal cell types in the retina, the RPE, the vascular endothelium and components of the extracellular matrix. The many interprotein relationships exemplify the complexity of eye growth and provide a challenge to developing strategies to prevent pathological eye elongation.
In conclusion, by using a cross-ancestry design in a large study population on common refractive errors, we identified numerous novel loci and pathways involved in eye growth. Our multidisciplinary approach incorporating GWAS data with in silico analyses and expression experiments provides an example for the design of future genetic studies for complex traits. Additional genetic insights into refractive errors will be gained by increasing sample size and genotyping depth; by performing family studies to identify rare alleles with large effects; and by evaluating population extremes. Our list of plausible genes and pathways provides a plethora of data for future studies focusing on gene-environment interaction and on translation of GWAS findings into starting points for therapy. 
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Methods
Methods, including statements of data availability and any associated accession codes and references, are available at https://doi. org/10.1038/s41588-018-0127-7. of the differences in effect-size scaling. 23andMe used a less accurate phenotype variable (AODM): the effective sample size for 23andMe was approximately equivalent to the effective sample size of CREAM-ALL (Fig. 2b) , and thus weighting by (1/√ n effective ) yielded a final weighting ratio of 1:1 (ref. 101 ). Genomewide statistical significance was defined at P < 5.0 × 10 -8 (ref. 102 ).
All three meta-analysis stages were performed under genomic control. Studyspecific and meta-analysis lambda (λ ) estimates are shown in Supplementary Fig. 6 ; to check for confounding biases (for example, cryptic relatedness and population stratification), LD-score intercepts from LD-score regressions per ancestry were constructed 30 (Supplementary Fig. 7) . To check the robustness of signals, we ran conventional random-effects models in METASOFT, and fixed-effects models weighted on sample size and on weights estimated from standard error per allele were tested in METAL (Supplementary Table 2 and Supplementary Table 3 ).
Manhattan (modified version of package 'qqman'), regional, box and forest plots were made in R version 3.2.3 and LocusZoom 103 . An overview of the Hardy-Weinberg P of all index variants per cohort can be found in Supplementary  Table 4 . The comparison between refractive error and age of onset was performed in the LDSC program 30 .
Population stratification and heritability calculations.
Each study assessed the degree of genetic admixture and stratification in study participants through the use of principal components. Homogeneity of participants was ensured by removal of all individuals whose ancestry did not match the prevailing ancestral group. We used genomic inflation factors to control for admixture and stratification, and performed genomic-controlled meta-analysis to account for the effects of any residual heterogeneity. To further distinguish between inflation from a true polygenic signal and population stratification, we examined the relationship between test statistics and LD with LDSC. CREAM-EUR, CREAM-ASN and 23andMe were evaluated separately; variants not present in HapMap3 and with MAF < 1% were excluded. SNP heritability estimates were calculated in LDSC for the same set of genetic variants.
Locus definition and annotation.
All study effect-size estimates were oriented to the positive strand of the NCBI Build 37 reference sequence of the human genome. The index variant of a locus was defined as the variant with the lowest P in a region spanning a 100-kb window of the outermost genome-wide-significant variant of that same region. We annotated all index variants in the web version of ANNOVAR 104 based on UCSC Known Gene Database 34 . For variants within the coding sequence or 5′ or 3′ UTRs of a gene, that gene was assigned to the index variant (this procedure led to more than one gene being assigned to variants located within the transcription units of multiple overlapping genes). For variants in intergenic regions, the nearest 5′ gene and the nearest 3′ gene were assigned to the variant. Index variants were annotated to functional RNA elements when they were described as such in the UCSC Known Gene Database. We used conservation (PhyloP 105 ) and prediction tools (SIFT 38 , MutationTaster 106 , align GVGD 39, 40 and PolyPhen-2 (ref. 35 )) to predict the pathogenicity of protein-altering exonic variants.
Conditional signal analysis.
We performed conditional analysis to identify additional independent signals near the index variant at each locus, by using GCTA-COJO 32 . We transformed the Z scores of the summary statistics to betas with the following formula: = ∕ × − N MAF MAF standard error 1 2 ( 1 ). We performed the GCTA-COJO analysis 32 by using summary-level statistics from the meta-analysis on all cohorts. LD between variants was estimated from RSI-III.
Replication in UK Biobank. The UKEV Consortium performed a GWAS of refractive error in 95,505 participants of European ancestry who were 37-73 years of age and had no history of eye disorders 33 . Refractive error was measured with an autorefractor; SphE was calculated per eye and averaged between the two eyes. To account for relatedness, a mixed-model analysis with BOLT-LMM was used 107 , including age, sex, genotyping array and the first ten principal components as covariates. Analysis was restricted to markers present in the HRC reference panel 108 . We performed lookups for all independent genetic variants identified in our stage 3 meta-analysis and conditional analysis. For 16 variants not present in UKEV, we performed lookups for a surrogate variant in high LD (r 2 > 0.8). When more than one potential surrogate variant was available, the variant in strongest LD with the index variant was selected. Six variants were not available for replication: one variant (rs188159083) was neither present on the array nor was a surrogate available in UKEV, and five variants showed evidence of departure from HWE (HWE exact test P < 3.0 × 10 −4 ).
Post-GWAS analyses. We performed two gene-based tests to identify additional significant genes not found in the single-variant analysis. First, we applied the gene-based test implemented in fastBAT 41 to the per-variant summary statistics of the meta-analysis of all European cohorts (23andMe and CREAM-EUR). We used the default parameters (all variants in or within 50 kb of a gene) and focused on variants with a gene-based P < 2 × 10 −6 (Bonferroni correction based on 25,000 genes) and per-variant P > 5 × 10 −8 . Second, we applied another genebased test in EUGENE 42 , which includes only variants that are eQTLs (Genotype Tissue Expression (GTEx) data, blood 109 ). EUGENE tests a hypothesis predicated on eQTLs as key drivers of the association signal. eQTLs within 50 kb of a gene were included in the test. Genes with EUGENE P < 2 × 10 −6 (and not found in the single variant analysis) were considered significant. Finally, we used functional annotation information from genome-wide-significant loci to reweigh results in fgwas (version 0.3.64 (ref. 43-) ). Fgwas incorporates functional annotation (for example, DNase I-hypersensitive sites in various tissues and 3′ -UTR regions) to reweight data from GWAS and uses a Bayesian model to calculate a posterior probability of association. This approach can identify risk loci that otherwise might not reach the genome-wide-significance threshold in standard GWAS. Details about this approach can be found in the Supplementary Note.
Refractive errors and myopia risk prediction. To assess the risk of the entire range of refractive errors, we computed PGRS values for the population-based RSI-III, using the P and Z scores from a meta-analysis on CREAM-ALL and 23andMe, excluding the RSI-III cohorts. Only variants with high imputation quality (IMPUTE info score > 0.5 or minimac Rsq > 0.8) and MAF > 1% were considered. P-based clumping was performed in PLINK 110 , with an r 2 threshold of 0.2 and a physical-distance threshold of 500 kb, excluding the MHC region. This procedure resulted in a total of 243,938 variants. For each individual in RSI, RSII and RSIII (n = 10,792), PGRS values were calculated with the --score command in PLINK across the following strata of P thresholds: 5.0 × 10 −8 , 5.0 × 10 −7 , 5.0 × 10 −6 , 5.0 × 10 −5 , 5.0 × 10 −4 , 0.005, 0.01, 0.05, 0.1, 0.5, 0.8 and 1.0. The proportion of variance explained by each PGRS model was calculated as the difference in the R 2 between two regression models: one in which SphE was regressed on age, sex and the first five principal components, and the other also including the PGRS as an additional covariate. Subsequently, areas under the receiver operating characteristic curve were calculated for myopia (SphE ≤ -3 s.d.) vs. hyperopia (SphE ≥ + 3 s.d.).
Genetic correlation between ancestries. We used Popcorn 47 to investigate ancestry-related differences in the genetic architecture of refractive error and myopia. Popcorn takes summary GWAS statistics from two populations and LD information from ancestry-matched reference panels, and computes genetic correlations by implementing a weighted likelihood function that accounts for the inflation of Z scores due to LD. Pairwise analyses were carried out by using the GWAS summary statistics from 23andMe (n = 104,292), CREAM-EUR (n = 44,192) and CREAM-EAS (n = 9,826) meta-analyses. Only SNPs with MAF ≥ 5% were included, thus resulting in a final set of 3,625,602 SNPs for analyses involving 23andMe and 3,642,928 SNPs for the CREAM-EUR vs. CREAM-EAS analysis. Reference panels were constructed with genotype data from 503 European and 504 East Asian individuals sequenced as part of the 1000 Genomes Project (release 2 May 2013; see URLs). The reference-panel VCF files were filtered in PLINK 110 to remove indels, strand-ambiguous variants, variants without an 'rs' ID prefix and variants located in the MHC region on chromosome 6 (chromosome 6: 25000000-33500000; build 37).
Analysis between phenotypes.
To evaluate the consistency of genotypic effects across studies that used different phenotype definitions, we compared effect sizes from GWAS studies of either SphE or AODM in Europeans, i.e., CREAM-EUR (n = 44,192) or 23andMe (n = 104,293), respectively. Marker-wise additive genetic effect sizes (in diopters per copy of the risk allele) for SphE were compared against those (in units log(HR) per copy of the risk allele) for AODM. Data were visualized with R. Genetic correlation between the two phenotypes SphE and AODM was calculated through LD-score regression. This analysis included all common SNPs (MAF > 0.01) present in HapMap3.
Evidence of functional involvement. To rank genes according to biological plausibility, we scored annotated genes according to our own findings and published reports of a potential functional role in refractive error. Points were assigned for each gene on the basis of ten categories (details on the methodology per category are provided in Supplementary Note): internal replication of index genetic variants in the individual cohort GWAS analyses through Bonferroni correction (CREAM-ASN, CREAM-EUR and 23andMe; P Bonferroni 1.19 × 10 −4 ); evidence of eQTL from FUMA 32 analysis and extensive lookups in GTEx; evidence of expression in the eye in developmental ocular tissues; evidence of expression in the eye in adult ocular tissues; presence of an eye phenotype in knockout mice (Mouse Genome Informatics and International Mouse Phenotyping Consortium databases); presence of an eye phenotype in humans (OMIM; see URLs, DisGeNET 111 ); location in a functional region of a gene (wANNOVAR; see URLs); presence of the gene in a significant enriched functional pathway with FDR < 0.05 (DEPICT 48 ); presence of the gene in the gene priority analysis of DEPICT with FDR < 0.05; and presence of the gene in the canonical pathway analysis of IPA (see URLs). Furthermore, we performed a systematic search for each gene to assess its potential as a drug target (SuperTarget 112 , STITCH 113 , DrugBank 114 and PharmaGkb 115 ). All information derived from this study and the literature was used to annotate genes to retinal cell types.
Genetic pleiotropy. To investigate the overlap of genes with other common traits, we performed a lookup in the GWAS catalog by using FUMA. Multiple-testing correction (i.e., Benjamini-Hochberg) was performed. Traits were significantly associated when adjusted P ≤ 0.05, and the number of genes that overlapped with the GWAS-catalog gene sets was ≥ 2.
Reporting Summary. Further information on experimental design is available in the Nature Research Reporting Summary linked to this article. Data availability. The summary statistics of the stage 3 meta-analysis are included in Supplementary Data 3. To protect the privacy of the participants in our cohorts, further summary statistics of stage 1 (CREAM) and stage 2 (23andMe) will be available upon reasonable request. Please contact c.c.w.klaver@erasmusmc.nl (CREAM) and/or apply.research@23andMe.com (23andMe) for more information and to access the data.
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Statistical parameters
For all figures and tables that use statistical methods, confirm that the following items are present in relevant figure legends (or the Methods section if additional space is needed).
n/a Confirmed
The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement (animals, litters, cultures, etc.)
A description of how samples were collected, noting whether measurements were taken from distinct samples or whether the same sample was measured repeatedly.
A statement indicating how many times each experiment was replicated
The statistical test(s) used and whether they are one-or two-sided (note: only common tests should be described solely by name; more complex techniques should be described in the Methods section)
A description of any assumptions or corrections, such as an adjustment for multiple comparisons The test results (e.g. p values) given as exact values whenever possible and with confidence intervals noted A summary of the descriptive statistics, including central tendency (e.g. median, mean) and variation (e.g. standard deviation, interquartile range)
Clearly defined error bars
See the web collection on statistics for biologists for further resources and guidance.
